The combination of placenta-derived stem cells (PMSCs) with standard in utero repair for severe spina bifida appears feasible and safe, with no cell-related adverse events observed at birth, a ...
Neurons from grafted stem cells contain intrinsic codes for navigating and forming connections, which may improve cell therapy for a brain short-circuited by stroke. Some parts of our bodies bounce ...
For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...
Imagine if our bodies could grow new organs throughout our entire lives. Plants do this constantly, thanks to tiny, powerful reservoirs of stem cells. But how do these cells know when to divide, and ...
Dec 11 (Reuters) - A California clinic that specializes in stem cell therapy treatments is ending a $10 million lawsuit against U.S. law firm Venable, which had represented the clinic for years in a ...
Kylie Jenner is the latest A-lister hopping on the stem cell therapy bandwagon. The 28-year-old mom of two revealed that she recently underwent the procedure in the hopes of easing the “bad chronic ...
A man has become the seventh person to be left HIV-free after receiving a stem cell transplant to treat blood cancer. Significantly, he is also the second of the seven who received stem cells that ...
Texas A&M researchers found a way to make stem cells produce double the normal number of mitochondria using nanoflower particles. These energized stem cells then transfer their surplus “power packs” ...
A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely ...
Korean biotechnology company, Nature Cell, is planning to open a stem cell facility in Baltimore, bringing 500 new jobs, the governor announced Tuesday. The 100,000 square foot manufacturing facility ...
People who received an infusion of stem cells shortly after a heart attack were less likely to develop heart failure than those treated with standard care, according to the largest such trial to date.